Ocuphire Pharma, Inc. (OCUP)
NASDAQ: OCUP · IEX Real-Time Price · USD
1.990
+0.050 (2.58%)
At close: Jul 19, 2024, 4:00 PM
1.940
-0.050 (-2.51%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ocuphire Pharma Stock Forecast
OCUP's stock price has decreased by -51.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Ocuphire Pharma stock have an average target of 18.75, with a low estimate of 17 and a high estimate of 20. The average target predicts an increase of 842.21% from the current stock price of 1.99.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2024.
Analyst Ratings
The average analyst rating for OCUP stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +905.03% | May 13, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $22 → $18 | Strong Buy | Maintains | $22 → $18 | +804.52% | May 13, 2024 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $24 → $20 | Strong Buy | Maintains | $24 → $20 | +905.03% | Mar 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +905.03% | Mar 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +905.03% | Nov 14, 2023 |
Financial Forecast
Revenue This Year
16.68M
from 19.05M
Decreased by -12.43%
Revenue Next Year
66.35M
from 16.68M
Increased by 297.75%
EPS This Year
-0.71
from -0.46
EPS Next Year
0.84
from -0.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 35.4M | 154.8M | 240.0M | 344.8M | 140.2M |
Avg | 16.7M | 66.4M | 111.9M | 218.4M | 136.2M |
Low | 7.2M | 13.8M | 35.4M | 97.9M | 130.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 86.0% | 828.0% | 261.6% | 208.1% | -35.8% |
Avg | -12.4% | 297.7% | 68.6% | 95.2% | -37.7% |
Low | -62.3% | -17.2% | -46.6% | -12.5% | -40.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.18 | 4.20 | 5.81 | 8.81 | 1.83 |
Avg | -0.71 | 0.84 | 1.89 | 4.76 | 1.77 |
Low | -1.14 | -0.98 | -0.20 | 0.93 | 1.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 588.6% | 366.0% | -61.6% |
Avg | - | - | 124.2% | 152.0% | -62.7% |
Low | - | - | - | -50.8% | -64.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.